carbon monoxide has been researched along with Pulmonary Sarcoidosis in 18 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Excerpt | Relevance | Reference |
---|---|---|
"67Ga lung uptake, obtained by a standardized computer-assisted quantitative method of 67Ga scintigraphy, was compared to carbon monoxide diffusion capacity (DLCO) in 45 patients with biopsy proven pulmonary sarcoidosis." | 7.68 | Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis. ( Alberts, C; Jansen, HM; Kuipers, AF; Roos, CM; van der Schoot, JB, 1993) |
"In 149 patients with proven pulmonary sarcoidosis the alveolar-arterial oxygen pressure gradient (P(A-a)O(2)) during exercise was assessed and compared with chest X-ray typing, pulmonary function, single breath-diffusing capacity for carbon monoxide (DL(CO)), serological markers, cell composition of bronchoalveolar lavage fluid (BALF) and clinical course." | 3.77 | The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. ( Arzt, M; Budweiser, S; Geck, B; Hamer, OW; Heidinger, D; Jörres, RA; Kollert, F; Müller-Quernheim, J; Pfeifer, M; Prasse, A; Suchy, R, 2011) |
"67Ga lung uptake, obtained by a standardized computer-assisted quantitative method of 67Ga scintigraphy, was compared to carbon monoxide diffusion capacity (DLCO) in 45 patients with biopsy proven pulmonary sarcoidosis." | 3.68 | Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis. ( Alberts, C; Jansen, HM; Kuipers, AF; Roos, CM; van der Schoot, JB, 1993) |
"Sarcoidosis is a systemic inflammatory disease characterized by non-necrotizing granulomas in involved organs, most commonly the lung." | 1.46 | Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort. ( Arger, NK; Benn, BS; Gelfand, JM; Gomez, A; Ho, M; Kidd, SA; Koth, LL; Lehman, Z; Nguyen, CP; Ramstein, J; Su, R; Sun, S, 2017) |
"Different interstitial lung diseases may show distinct lymphocyte activation profiles." | 1.36 | T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells? ( Claessen, AM; Grutters, JC; Heron, M; van den Bosch, JM, 2010) |
"Pulmonary fibrosis is defined by an overgrowth of fibroblasts and extracellular matrix deposition, and results in respiratory dysfunction that is often fatal." | 1.36 | MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. ( Grutters, JC; Kazemier, KM; Korthagen, NM; Nagtegaal, MM; van den Bosch, JM; van Moorsel, CH, 2010) |
"Pulmonary hypertension was found in 34." | 1.36 | [Sarcoidosis. Clinical presentation and prognosis]. ( Cáneva, J; González, EL; Vigliano, C, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 11 (61.11) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Shlobin, OA | 1 |
Kouranos, V | 2 |
Barnett, SD | 1 |
Alhamad, EH | 1 |
Culver, DA | 1 |
Barney, J | 1 |
Cordova, FC | 1 |
Carmona, EM | 1 |
Scholand, MB | 1 |
Wijsenbeek, M | 1 |
Ganesh, S | 1 |
Lower, EE | 1 |
Engel, PJ | 1 |
Wort, J | 1 |
Price, L | 1 |
Wells, AU | 3 |
Nathan, SD | 1 |
Baughman, RP | 2 |
Benn, BS | 1 |
Lehman, Z | 1 |
Kidd, SA | 1 |
Ho, M | 1 |
Sun, S | 1 |
Ramstein, J | 1 |
Arger, NK | 1 |
Nguyen, CP | 1 |
Su, R | 1 |
Gomez, A | 1 |
Gelfand, JM | 1 |
Koth, LL | 1 |
Kaminsky, DA | 1 |
Jarzembowski, SC | 1 |
Zappala, CJ | 1 |
Desai, SR | 1 |
Copley, SJ | 1 |
Spagnolo, P | 1 |
Sen, D | 1 |
Alam, SM | 1 |
du Bois, RM | 1 |
Hansell, DM | 1 |
Lill, H | 1 |
Kliiman, K | 1 |
Altraja, A | 1 |
Ciarleglio, G | 1 |
Refini, RM | 1 |
Pieroni, MG | 1 |
Martino, VA | 1 |
Bargagli, E | 1 |
Rottoli, P | 1 |
Sestini, P | 1 |
Heron, M | 1 |
Claessen, AM | 1 |
Grutters, JC | 2 |
van den Bosch, JM | 2 |
Korthagen, NM | 1 |
Nagtegaal, MM | 1 |
van Moorsel, CH | 1 |
Kazemier, KM | 1 |
Kollert, F | 1 |
Geck, B | 1 |
Suchy, R | 1 |
Jörres, RA | 1 |
Arzt, M | 1 |
Heidinger, D | 1 |
Hamer, OW | 1 |
Prasse, A | 1 |
Müller-Quernheim, J | 1 |
Pfeifer, M | 1 |
Budweiser, S | 1 |
González, EL | 1 |
Vigliano, C | 1 |
Cáneva, J | 1 |
Erdal, BS | 1 |
Crouser, ED | 1 |
Yildiz, V | 1 |
King, MA | 1 |
Patterson, AT | 1 |
Knopp, MV | 1 |
Clymer, BD | 1 |
Marcellis, RG | 1 |
Lenssen, AF | 1 |
de Vries, GJ | 1 |
van der Grinten, CP | 1 |
Verschakelen, JA | 1 |
De Vries, J | 1 |
Drent, M | 1 |
Rapti, A | 1 |
Gialafos, E | 1 |
Aggeli, K | 1 |
Moyssakis, J | 1 |
Kallianos, A | 1 |
Kostopoulos, C | 1 |
Anagnostopoulou, O | 1 |
Sfikakis, PP | 1 |
Tzelepis, GE | 1 |
Mihailovic-Vucinic, V | 1 |
Zugic, V | 1 |
Videnovic-Ivanov, J | 1 |
Phansalkar, AR | 1 |
Hanson, CM | 1 |
Shakir, AR | 1 |
Johnson, RL | 1 |
Hsia, CC | 1 |
Lamberto, C | 1 |
Nunes, H | 1 |
Le Toumelin, P | 1 |
Duperron, F | 1 |
Valeyre, D | 1 |
Clerici, C | 1 |
Kadota, J | 1 |
Mizunoe, S | 1 |
Mito, K | 1 |
Mukae, H | 1 |
Yoshioka, S | 1 |
Kawakami, K | 1 |
Koguchi, Y | 1 |
Fukushima, K | 1 |
Kon, S | 1 |
Kohno, S | 1 |
Saito, A | 1 |
Uede, T | 1 |
Nasu, M | 1 |
Kuipers, AF | 1 |
Alberts, C | 1 |
Roos, CM | 1 |
van der Schoot, JB | 1 |
Jansen, HM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Physical Training in Sarcoidosis Patients With Fatigue Complaints[NCT02243995] | 40 participants (Actual) | Interventional | 2013-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for carbon monoxide and Pulmonary Sarcoidosis
Article | Year |
---|---|
New observations on pulmonary function changes in sarcoidosis.
Topics: Bronchial Provocation Tests; Carbon Monoxide; Humans; Respiratory Function Tests; Sarcoidosis, Pulmo | 2003 |
17 other studies available for carbon monoxide and Pulmonary Sarcoidosis
Article | Year |
---|---|
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
Topics: Aged; Carbon Monoxide; Cardiac Catheterization; Female; Forced Expiratory Volume; Hemodynamics; Huma | 2020 |
Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.
Topics: Adult; Age Factors; Aged; Black or African American; Carbon Monoxide; Case-Control Studies; Cohort S | 2017 |
Influence of Mouth Pressure on Measurement of Diffusing Capacity in the Clinical Pulmonary Function Laboratory.
Topics: Adult; Aged; Asthma; Breath Holding; Carbon Monoxide; Dyspnea; Female; Forced Expiratory Volume; Hum | 2019 |
Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data.
Topics: Adult; Breath Tests; Carbon Monoxide; Disease Progression; Female; Forced Expiratory Volume; Humans; | 2014 |
Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population.
Topics: Adult; Carbon Monoxide; Estonia; Female; Humans; Lung; Male; Middle Aged; Regression Analysis; Sarco | 2016 |
Exhaled carbon monoxide in sarcoidosis.
Topics: Adult; Biomarkers; Breath Tests; Carbon Monoxide; Carboxyhemoglobin; Diagnosis, Differential; Exhala | 2008 |
T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?
Topics: Adrenal Cortex Hormones; Adult; Aged; Alveolitis, Extrinsic Allergic; Antigens, CD; Bronchoalveolar | 2010 |
MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Topics: Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; Calgranulin B; Carbon Monoxide; Cell Count; F | 2010 |
The impact of gas exchange measurement during exercise in pulmonary sarcoidosis.
Topics: Adult; Bronchoalveolar Lavage Fluid; Carbon Monoxide; Exercise Test; Exercise Tolerance; Female; Hum | 2011 |
[Sarcoidosis. Clinical presentation and prognosis].
Topics: Adult; Aged; Argentina; Carbon Monoxide; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; | 2010 |
Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis.
Topics: Carbon Monoxide; Humans; Image Processing, Computer-Assisted; Lung; Respiratory Function Tests; Sarc | 2012 |
Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?
Topics: Adult; Biomarkers; Breath Tests; Carbon Monoxide; Exercise Test; Exercise Tolerance; Female; Humans; | 2013 |
Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.
Topics: Adult; Aged; Arterial Pressure; Biomarkers; Carbon Monoxide; Comorbidity; Cross-Sectional Studies; F | 2013 |
Nitric oxide diffusing capacity and alveolar microvascular recruitment in sarcoidosis.
Topics: Adult; Analysis of Variance; Bias; Blood Volume; Breath Tests; Carbon Monoxide; Cardiac Output; Case | 2004 |
Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.
Topics: Adult; Capillaries; Carbon Monoxide; Exercise Test; Female; Humans; Male; Membranes; Middle Aged; Mu | 2004 |
High plasma concentrations of osteopontin in patients with interstitial pneumonia.
Topics: Adult; Aged; Biomarkers; Carbon Monoxide; Female; Humans; Immunoenzyme Techniques; Lung Diseases, In | 2005 |
Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis.
Topics: Adult; Carbon Monoxide; Female; Gallium Radioisotopes; Humans; Lung; Male; Pulmonary Diffusing Capac | 1993 |